Zaheer Yousef

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

Iacopo Olivotto, Artur Oręziak, Roberto Barriales‐Villa et al. · The Lancet · 2020 · 1.1K citations · Full text

Cardiomyopathy, Structural Heart Disease, Cardiovascular Disease +2

Outcomes of Cardiac Screening in Adolescent Soccer Players

Aneil Malhotra, Harshil Dhutia, Gherardo Finocchiaro et al. · New England Journal of Medicine · 2018 · 295 citations · Full text

Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy

S. Chalil, Paul Foley, Sarkaw A. Muyhaldeen et al. · EP Europace · 2007 · 185 citations · Full text

Optimized Implementation of Cardiac Resynchronization Therapy: A Call for Action for Referral and Optimization of Care

Wilfried Müllens, Angelo Auricchio, Pieter Martens et al. · European Journal of Heart Failure · 2020 · 153 citations · Full text

Heart Failure, Cardiac Anaesthesia, Device Therapy +16

Late intervention after anterior myocardial infarction: effects on left ventricular size, function, quality of life, and exercise tolerance

Zaheer Yousef, Simon Redwood, C. Bucknall et al. · Journal of the American College of Cardiology · 2002 · 132 citations

Physical Activity, Heart Failure, Diastolic Function +17